JI LIN AO DONG released its performance for the first half of the year, with a net profit attributable to the parent company of 1.282 billion yuan, an increase of 138.44%

JI LIN AO DONG released its semi-annual report for 2025, with a net profit attributable to shareholders of RMB 1.282 billion, a year-on-year increase of 138.44%. Operating revenue was RMB 1.126 billion, a year-on-year decrease of 20.21%. The net profit excluding non-recurring gains and losses was RMB 1.167 billion, a year-on-year increase of 43.68%. The basic earnings per share were RMB 1.0915, and it proposed to distribute a cash dividend of RMB 2.00 for every 10 shares to all shareholders. Revenue from the pharmaceutical and chain pharmacy business was RMB 1.016 billion, accounting for 90.22%, a decrease of 16.31% compared to the same period last year